These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 21598254)

  • 1. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.
    Liu Y; Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
    J Pathol; 2011 Sep; 225(1):54-62. PubMed ID: 21598254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease.
    Liu Y; Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
    J Neurochem; 2009 Oct; 111(1):242-9. PubMed ID: 19659459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced insulin-induced phosphatidylinositol-3-kinase activation in peripheral blood mononuclear leucocytes from patients with Alzheimer's disease.
    Castri P; Iacovelli L; De Blasi A; Giubilei F; Moretti A; Tari Capone F; Nicoletti F; Orzi F
    Eur J Neurosci; 2007 Nov; 26(9):2469-72. PubMed ID: 17986027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rise and fall of insulin signaling in Alzheimer's disease.
    Chami B; Steel AJ; De La Monte SM; Sutherland GT
    Metab Brain Dis; 2016 Jun; 31(3):497-515. PubMed ID: 26883429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.
    Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX
    J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain I Activation Causes GLUT3 Proteolysis and Downregulation of O-GlcNAcylation in Alzheimer's Disease Brain.
    Gu J; Jin N; Ma D; Chu D; Iqbal K; Gong CX; Liu F
    J Alzheimers Dis; 2018; 62(4):1737-1746. PubMed ID: 29614685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease.
    Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F
    Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease.
    Deng Y; Li B; Liu Y; Iqbal K; Grundke-Iqbal I; Gong CX
    Am J Pathol; 2009 Nov; 175(5):2089-98. PubMed ID: 19815707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.
    Xu W; Liu J; Ma D; Yuan G; Lu Y; Yang Y
    PLoS One; 2017; 12(2):e0172477. PubMed ID: 28225806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.
    Kurbatskaya K; Phillips EC; Croft CL; Dentoni G; Hughes MM; Wade MA; Al-Sarraj S; Troakes C; O'Neill MJ; Perez-Nievas BG; Hanger DP; Noble W
    Acta Neuropathol Commun; 2016 Mar; 4():34. PubMed ID: 27036949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer's Disease.
    Rasool M; Malik A; Waquar S; Zaheer A; Asif M; Iqbal Z; Gauthaman K; Kamal MA; Pushparaj PN
    CNS Neurol Disord Drug Targets; 2021; 20(7):602-612. PubMed ID: 33583389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1-40/42 and Phospho-Tau May Abet Alzheimer Development.
    Sajan M; Hansen B; Ivey R; Sajan J; Ari C; Song S; Braun U; Leitges M; Farese-Higgs M; Farese RV
    Diabetes; 2016 Jul; 65(7):1892-903. PubMed ID: 26895791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
    Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
    J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets.
    Chauhan A; Dubey S; Jain S
    Cell Biochem Funct; 2024 Sep; 42(7):e4111. PubMed ID: 39228117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62.
    Jung HJ; Kim YJ; Eggert S; Chung KC; Choi KS; Park SA
    Exp Neurol; 2013 Oct; 248():441-50. PubMed ID: 23906983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous administration of liraglutide ameliorates Alzheimer-associated tau hyperphosphorylation in rats with type 2 diabetes.
    Yang Y; Zhang J; Ma D; Zhang M; Hu S; Shao S; Gong CX
    J Alzheimers Dis; 2013; 37(3):637-48. PubMed ID: 23948890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.
    Liu F; Shi J; Tanimukai H; Gu J; Gu J; Grundke-Iqbal I; Iqbal K; Gong CX
    Brain; 2009 Jul; 132(Pt 7):1820-32. PubMed ID: 19451179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin.
    Jolivalt CG; Lee CA; Beiswenger KK; Smith JL; Orlov M; Torrance MA; Masliah E
    J Neurosci Res; 2008 Nov; 86(15):3265-74. PubMed ID: 18627032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.